Log in

NYSE:CMD - Cantel Medical Stock Price, Forecast & News

-0.58 (-0.83 %)
(As of 02/23/2020 09:00 AM ET)
Today's Range
Now: $69.50
50-Day Range
MA: $65.32
52-Week Range
Now: $69.50
Volume310,734 shs
Average Volume288,787 shs
Market Capitalization$2.96 billion
P/E Ratio69.50
Dividend Yield0.30%
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments



Sales & Book Value

Annual Sales$918.16 million
Cash Flow$3.36 per share
Book Value$15.84 per share


Net Income$55.04 million


Market Cap$2.96 billion
Next Earnings DateN/A

Receive CMD News and Ratings via Email

Sign-up to receive the latest news and ratings for CMD and its competitors with MarketBeat's FREE daily newsletter.

Cantel Medical (NYSE:CMD) Frequently Asked Questions

What is Cantel Medical's stock symbol?

Cantel Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "CMD."

How often does Cantel Medical pay dividends? What is the dividend yield for Cantel Medical?

Cantel Medical announced a Semi-Annual dividend on Wednesday, December 18th. Shareholders of record on Friday, January 17th will be paid a dividend of $0.105 per share on Friday, January 31st. The ex-dividend date of this dividend is Thursday, January 16th. This is a boost from Cantel Medical's previous Semi-Annual dividend of $0.10. View Cantel Medical's Dividend History.

How were Cantel Medical's earnings last quarter?

Cantel Medical Corp. (NYSE:CMD) announced its earnings results on Tuesday, December, 10th. The company reported $0.65 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.57 by $0.08. The business had revenue of $257.25 million for the quarter, compared to analysts' expectations of $250.70 million. Cantel Medical had a return on equity of 14.91% and a net margin of 4.38%. View Cantel Medical's Earnings History.

What price target have analysts set for CMD?

3 equities research analysts have issued 1-year price targets for Cantel Medical's stock. Their forecasts range from $82.00 to $108.00. On average, they expect Cantel Medical's stock price to reach $95.00 in the next year. This suggests a possible upside of 36.7% from the stock's current price. View Analyst Price Targets for Cantel Medical.

What is the consensus analysts' recommendation for Cantel Medical?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cantel Medical in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cantel Medical.

Has Cantel Medical been receiving favorable news coverage?

News headlines about CMD stock have trended positive this week, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cantel Medical earned a daily sentiment score of 2.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Cantel Medical.

Who are some of Cantel Medical's key competitors?

What other stocks do shareholders of Cantel Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cantel Medical investors own include THERAPIX BIOSCI/S (TRPX), Gilead Sciences (GILD), NVIDIA (NVDA), ZIOPHARM Oncology (ZIOP), JPMorgan Chase & Co. (JPM), Cisco Systems (CSCO), Exelixis (EXEL), Netflix (NFLX), Paypal (PYPL) and Supernus Pharmaceuticals (SUPN).

Who are Cantel Medical's key executives?

Cantel Medical's management team includes the folowing people:
  • Mr. Charles M. Diker, Chairman and Member of Office of the Chairman (Age 84)
  • Mr. George L. Fotiades, Pres, CEO & Vice Chairman (Age 65)
  • Mr. Peter G. Clifford, Exec. VP, CFO & Member of Office of the Chairman (Age 49)
  • Mr. Eric W. Nodiff, Exec. VP, Gen. Counsel, Corp. Sec. & Member of Office of the Chairman (Age 62)
  • Mr. Seth M. Yellin, Exec. VP of Strategy & Corp. Devel. and Member of Office of the Chairman (Age 45)

How do I buy shares of Cantel Medical?

Shares of CMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Cantel Medical's stock price today?

One share of CMD stock can currently be purchased for approximately $69.50.

How big of a company is Cantel Medical?

Cantel Medical has a market capitalization of $2.96 billion and generates $918.16 million in revenue each year. The company earns $55.04 million in net income (profit) each year or $2.37 on an earnings per share basis. Cantel Medical employs 2,775 workers across the globe.View Additional Information About Cantel Medical.

What is Cantel Medical's official website?

The official website for Cantel Medical is http://www.cantelmedical.com/.

How can I contact Cantel Medical?

Cantel Medical's mailing address is 150 CLOVE ROAD, LITTLE FALLS NJ, 07424. The company can be reached via phone at 973-890-7220 or via email at [email protected]

MarketBeat Community Rating for Cantel Medical (NYSE CMD)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  197 (Vote Outperform)
Underperform Votes:  208 (Vote Underperform)
Total Votes:  405
MarketBeat's community ratings are surveys of what our community members think about Cantel Medical and other stocks. Vote "Outperform" if you believe CMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel